NASDAQ: NKGen - “SNK01 autologous NK cell therapy demonstrated a positive effect on cerebral spinal fluid (“CSF”) and plasma Tau proteins in Alzheimer’s patients”
Confident in the NK tech, looking forward to phase 1 from ALA, outlook is positive.
NASDAQ: NKGen - “SNK01 autologous NK cell therapy demonstrated a...
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
-0.005(3.45%) |
Mkt cap ! $147.2M | |||
| Open | High | Low | Value | Volume |
| 14.5¢ | 15.0¢ | 14.0¢ | $123.9K | 855.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 968061 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 22086 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| ALA (ASX) Chart |